Medicis Pharmaceutical Corp. filed suit against Ranbaxy Inc. and Ranbaxy Laboratories Ltd. for allegedly trying to market a generic version of Medicis’ Solodyn, according to an 8-K filing with the U.S. Securities and Exchange Commission.

[News Source]